Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis - PubMed (original) (raw)
Review
Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis
T R Moukhtarian et al. Eur Psychiatry. 2017 Jul.
Abstract
Background: Emotional lability (EL) is an associated feature of attention-deficit/hyperactivity disorder (ADHD) in adults, contributing to functional impairment. Yet the effect of pharmacological treatments for ADHD on EL symptoms is unknown. We conducted a systematic review and meta-analysis to examine the effects of stimulants and atomoxetine on symptoms of EL and compare these with the effects on core ADHD symptoms.
Methods: A systematic search was conducted on the databases Embase, PsychInfo, and Ovid Medline® and the clinicaltrials.gov website. We included randomised, double-blind, placebo-controlled trials of stimulants and atomoxetine in adults aged 18-60 years, with any mental health diagnosis characterised by emotional or mood instability, with at least one outcome measure of EL. All identified trials were on adults with ADHD. A random-effects meta-analysis with standardised mean difference and 95% confidence intervals was used to investigate the effect size on EL and compare this to the effect on core ADHD symptoms.
Results: Of the 3,864 publications identified, nine trials met the inclusion criteria for the meta-analysis. Stimulants and atomoxetine led to large mean weighted effect-sizes for on ADHD symptoms (n=9, SMD=-0.8, 95% CI:-1.07 to -0.53). EL outcomes showed more moderate but definite effects (n=9, SMD=-0.41, 95% CI:-0.57 to -0.25).
Conclusions: In this meta-analysis, stimulants and atomoxetine were moderately effective for EL symptoms, while effect size on core ADHD symptoms was twice as large. Methodological issues may partially explain the difference in effect size. Reduced average effect size could also reflect heterogeneity of EL with ADHD pharmacotherapy responsive and non-responsive sub-types. Our findings indicate that EL may be less responsive than ADHD symptoms overall, perhaps indicating the need for adjunctive psychotherapy in some cases. To clarify these questions, our findings need replication in studies selecting subjects for high EL and targeting EL as the primary outcome.
Keywords: Atomoxetine; Attention-deficit/hyperactivity disorder; Emotional lability; Meta-analysis; Stimulants; Systematic review.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.
Similar articles
- Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders.
Osland ST, Steeves TD, Pringsheim T. Osland ST, et al. Cochrane Database Syst Rev. 2018 Jun 26;6(6):CD007990. doi: 10.1002/14651858.CD007990.pub3. Cochrane Database Syst Rev. 2018. PMID: 29944175 Free PMC article. Review. - Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis.
Rodrigues R, Lai MC, Beswick A, Gorman DA, Anagnostou E, Szatmari P, Anderson KK, Ameis SH. Rodrigues R, et al. J Child Psychol Psychiatry. 2021 Jun;62(6):680-700. doi: 10.1111/jcpp.13305. Epub 2020 Aug 26. J Child Psychol Psychiatry. 2021. PMID: 32845025 - Pharmacotherapy of emotional dysregulation in adults with ADHD: A systematic review and meta-analysis.
Lenzi F, Cortese S, Harris J, Masi G. Lenzi F, et al. Neurosci Biobehav Rev. 2018 Jan;84:359-367. doi: 10.1016/j.neubiorev.2017.08.010. Epub 2017 Aug 26. Neurosci Biobehav Rev. 2018. PMID: 28837827 Review. - Adverse drug events related to mood and emotion in paediatric patients treated for ADHD: A meta-analysis.
Pozzi M, Carnovale C, Peeters GGAM, Gentili M, Antoniazzi S, Radice S, Clementi E, Nobile M. Pozzi M, et al. J Affect Disord. 2018 Oct 1;238:161-178. doi: 10.1016/j.jad.2018.05.021. Epub 2018 May 22. J Affect Disord. 2018. PMID: 29883938 Review. - Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.
Hennissen L, Bakker MJ, Banaschewski T, Carucci S, Coghill D, Danckaerts M, Dittmann RW, Hollis C, Kovshoff H, McCarthy S, Nagy P, Sonuga-Barke E, Wong IC, Zuddas A, Rosenthal E, Buitelaar JK; ADDUCE consortium. Hennissen L, et al. CNS Drugs. 2017 Mar;31(3):199-215. doi: 10.1007/s40263-017-0410-7. CNS Drugs. 2017. PMID: 28236285 Free PMC article. Review.
Cited by
- Mainstreaming adult ADHD into primary care in the UK: guidance, practice, and best practice recommendations.
Asherson P, Leaver L, Adamou M, Arif M, Askey G, Butler M, Cubbin S, Newlove-Delgado T, Kustow J, Lanham-Cook J, Findlay J, Maxwell J, Mason P, Read H, van Rensburg K, Müller-Sedgwick U, Sedgwick-Müller J, Skirrow C. Asherson P, et al. BMC Psychiatry. 2022 Oct 11;22(1):640. doi: 10.1186/s12888-022-04290-7. BMC Psychiatry. 2022. PMID: 36221085 Free PMC article. - Emotion dysregulation in attention-deficit/hyperactivity disorder and borderline personality disorder.
Moukhtarian TR, Mintah RS, Moran P, Asherson P. Moukhtarian TR, et al. Borderline Personal Disord Emot Dysregul. 2018 May 20;5:9. doi: 10.1186/s40479-018-0086-8. eCollection 2018. Borderline Personal Disord Emot Dysregul. 2018. PMID: 29796281 Free PMC article. Review. - A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD).
Cortese S, Newcorn JH, Coghill D. Cortese S, et al. CNS Drugs. 2021 Oct;35(10):1035-1051. doi: 10.1007/s40263-021-00848-3. Epub 2021 Aug 17. CNS Drugs. 2021. PMID: 34403134 Review. - Self-rated costs and benefits of conventional and alternative adult ADHD treatments.
Haijen ECHM, Hurks PPM, Kuypers KPC. Haijen ECHM, et al. Sci Rep. 2024 Nov 14;14(1):28046. doi: 10.1038/s41598-024-79025-7. Sci Rep. 2024. PMID: 39543226 Free PMC article. - Comparable emotional dynamics in women with ADHD and borderline personality disorder.
Moukhtarian TR, Reinhard I, Moran P, Ryckaert C, Skirrow C, Ebner-Priemer U, Asherson P. Moukhtarian TR, et al. Borderline Personal Disord Emot Dysregul. 2021 Feb 12;8(1):6. doi: 10.1186/s40479-021-00144-y. Borderline Personal Disord Emot Dysregul. 2021. PMID: 33579385 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous